In Reply We thank Chang et al for their interest and insight regarding our evidence-based approach to improve continuous renal replacement therapy (CRRT) utilization at our institution.
Although the average duration of therapy per patient and the average direct cost per patient both decreased, the average direct cost per day using CRRT remained similar preintervention and postintervention. We believe that this change in treatment duration reflects the results of our efforts to encourage appropriate utilization of CRRT. Because we did not change the amount of resources used to provide 1 patient-day’s duration of treatment, the average direct cost per day on CRRT remained the same.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Alban RF, Tseng J, Rodriguez H. Standardization of Continuous Renal Replacement Therapy—Reply. JAMA Intern Med. 2018;178(7):1003. doi:10.1001/jamainternmed.2018.2676
Customize your JAMA Network experience by selecting one or more topics from the list below.